ArabFinance: GlaxoSmithKline’s (GSK Egypt) (BIOC) extraordinary general meeting (EGM) approved selling transferred consumer healthcare and intangible assets worth of EGP 1.179 billion to GSK Consumer Healthcare Egypt Limited, according to a statement filed to the Egyptian Exchange (EGX) on Sunday.
The EGM authorized the board of directors to conduct all necessary procedures relevant to the transactions, the statement noted.
GSK Egypt, a member of the British pharmaceutical company Glaxo Group, is an Egypt-based company engaged in the manufacture, packaging, marketing, sale, and distribution of pharmaceutical products.
Copyright 2022 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an as is and as available basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
